Veradigm Inc. and Holmusk jointly announced the next stage in its strategic collaboration. The collaboration draws on the strengths of each company to fuel innovation in behavioral health and create the evidence needed to move the field forward. In this new phase of the collaboration, cohorts of millions of behavioral health patients and related de-identified clinical data from Veradigm will be added to Holmusk?s NeuroBlu Database, a leading source for real-world data that shows how behavioral health care is delivered.

Veradigm is also making an additional financial investment in Holmusk, building on a collaboration launched early this year, when Veradigm became the lead investor in Holmusk?s Series B financing round. The collaboration expands Holmusk?s NeuroBlu Database by millions of patients. The NeuroBlu Database will now be able to power even more research and address challenging behavioral health questions that require the creation of targeted research cohorts.